Sotuvning operatsion marjasi: Immunocore Holdings (IMCR)

Immunocore Corp (IMCR) kompaniyasining korporativ logotipi

Mablag'larning barqaror oqimi munozarali tuyulishi mumkin bo'lsa-da, operatsion marjani kuzatish Immunocore Holdings plc (IMCR) biznesining barqarorligini tasdiqlaydi. Joriy daromadlilik, bunda -6.80 tegishli metrika qiymati hisoblanadi, uveal melanoma davolash uchun KIMMTRAK sotuvlariga asoslangan. Tullar shuningdek, onkologiya uchun T-hujayra retseptorlariga tayanadi. Ushbu innovatsiyalarning tibbiy e'tirofi pul oqimlarining uzoq muddatli himoyasini ta'minlaydi.

IMCR: immunocore.com Operatsion foyda normasi 04.07.2022 - 20.11.2026

Immunocore Holdings plc - tahliliy kesimlar va asosiy koʻrsatkichlar (IMCR)

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:IMCR, Immunocore
Immunocore Corp asosiy tovari

Uveal melanoma davolashidagi monopoliya maqomi Immunocore Holdings plc (IMCR) kompaniyasiga sezilarli narx belgilash imkoniyatini beradi. Ushbu ko'rsatkich soliqlar va qarz majburiyatlarining ta'sirini hisobga olmagan holda, operatsion foyda marjasini tushumning foizi sifatida o'lchaydi. Operatsion foyda foizidagi tendentsiya rahbariyatning tushumni haqiqiy daromadga aylantirish qobiliyatini namoyish etadi. Barqaror tendentsiya terapiya narxlarini maksimal darajada saqlagan holda, xarajatlar nazoratining samaradorligini tasdiqlaydi. Bu esa biznesning fundamental baholashining barqarorligini asoslaydi.

Immunocore Holdings plc kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi IBRX|JANX - Operatsion foyda bo'yicha marjinallik|Sotuvning operatsion marjasi RCUS (Arcus Bio)|Operatsion foyda koeffitsiyenti ZYME|Operatsion marja TNGX (Tango Therapeutics, Inc.)|Operatsion foyda normasi IOVA|immatics.com - Operatsion marja|Sotuvning operatsion rentabelligi Xencor Inc.|Compass Therapeutics (CMPX) - Operatsion rentabellik|Replimune Group, Inc. - Operatsion foyda normasi|LYEL (lyell.com) - Operatsion marja|Operatsion marja Innate Pharma SA|Operatsion rentabellik pyxisoncology.com (PYXS)|CGEN: Operatsion foyda marjasi|IO Biotech Inc - Sotuvning operatsion marjasi|sutrobio.com (STRO) - Sotuvning operatsion rentabelligi|INKT - Operatsion rentabellik|werewolftx.com (HOWL) - Sotuvning operatsion marjasi|Immix (IMMX) - Operatsion rentabellik|ALXO (ALX Oncology Holdings) - Operatsion rentabellik|Sotuvning operatsion marjasi CUE|PDS Biotechnology Corporation (PDSB) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Sonnet BioTherapeutics Holdings Inc. (SONN)|Operatsion marja MAIA Biotechnology Inc (MAIA)|Operatsion rentabellik Liminatus Pharma LIMN|Operatsion foyda normasi LVTX|NXTC: Sotuvning operatsion marjasi|leaptx.com - Operatsion foyda koeffitsiyenti|INTS: Operatsion marja|Sensei Biotherapeutics Inc - Operatsion foyda normasi|Sotuvning operatsion marjasi TOVX|Operatsion foyda bo'yicha sotuv rentabelligi GRTS (Gritstone bio, Inc.)|Sotuvning operatsion marjasi KA (kinetabio.com)|NEXI - Sotuvning operatsion rentabelligi|Turnstone Biologics - Sotuvning operatsion marjasi|Operatsion faoliyat rentabelligi Vaccinex Inc. (VCNX)|harpoontx.com - Operatsion marja